Latest news with #AAPS
Business Upturn
10 hours ago
- Health
- Business Upturn
The Association of American Physicians and Surgeons files an Amicus Brief in the Supreme Court in Support of the Right to Conversion Therapy
TUCSON, Ariz., June 16, 2025 (GLOBE NEWSWIRE) — The Association of American Physicians and Surgeons (AAPS) filed its amicus brief in the U.S. Supreme Court on June 12 against a Colorado ban on conversion therapy for minors, in Chiles v. Salazar (No. 24-539). In this case, a therapist challenges the Colorado law, similar to bans in roughly half the states, that prevents her from counseling in support of a patient's gender, while allowing transgender conversion advice. Colorado and most blue states censor therapists from helping teenagers overcome gender dysphoria and same-sex attractions. But therapists are permitted to encourage transgender transitions and homosexuality, the brief states. 'This is a blatant content-based discrimination by government in violation of the First Amendment,' observes AAPS General Counsel Andrew Schlafly. 'Government cannot lawfully pick sides with viewpoint censorship.' At issue before the Supreme Court is not whether conversion therapy, which is better called gender support therapy, is beneficial to most people. Instead, the issue is whether there is a free-speech right of licensed counselors to provide such talk therapy to patients, the brief explains. 'Physicians, therapists, and other caregivers are professionals not to be censored and controlled. They must retain First Amendment freedom of speech rights after licensure which they properly enjoyed prior to licensure,' the brief argues. AAPS quotes Supreme Court Justice Clarence Thomas in his dissent from a Court decision not to review a challenge to a similar Washington State law. Justice Thomas wrote in Tingley v. Ferguson (2023) that the State allows counseling of 'minors about gender dysphoria, but only if they convey the state-approved message of encouraging minors to explore their gender identities.' 'Expressing any other message is forbidden—even if the counselor's clients ask for help to accept their biological sex. That is viewpoint-based and content-based discrimination in its purest form,' Justice Thomas added. AAPS in its amicus brief urged the Court to invalidate Colorado's ban on conversion therapy. This would also negate similar laws in about half the country. The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties since 1943. Contact: Andrew Schlafly, (908) 719-8608, [email protected], or Jane M. Orient, M.D., (520) 323-3110, [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
12 hours ago
- Health
- Yahoo
The Association of American Physicians and Surgeons files an Amicus Brief in the Supreme Court in Support of the Right to Conversion Therapy
TUCSON, Ariz., June 16, 2025 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) filed its amicus brief in the U.S. Supreme Court on June 12 against a Colorado ban on conversion therapy for minors, in Chiles v. Salazar (No. 24-539). In this case, a therapist challenges the Colorado law, similar to bans in roughly half the states, that prevents her from counseling in support of a patient's gender, while allowing transgender conversion advice. Colorado and most blue states censor therapists from helping teenagers overcome gender dysphoria and same-sex attractions. But therapists are permitted to encourage transgender transitions and homosexuality, the brief states. 'This is a blatant content-based discrimination by government in violation of the First Amendment,' observes AAPS General Counsel Andrew Schlafly. 'Government cannot lawfully pick sides with viewpoint censorship.' At issue before the Supreme Court is not whether conversion therapy, which is better called gender support therapy, is beneficial to most people. Instead, the issue is whether there is a free-speech right of licensed counselors to provide such talk therapy to patients, the brief explains. 'Physicians, therapists, and other caregivers are professionals not to be censored and controlled. They must retain First Amendment freedom of speech rights after licensure which they properly enjoyed prior to licensure,' the brief argues. AAPS quotes Supreme Court Justice Clarence Thomas in his dissent from a Court decision not to review a challenge to a similar Washington State law. Justice Thomas wrote in Tingley v. Ferguson (2023) that the State allows counseling of 'minors about gender dysphoria, but only if they convey the state-approved message of encouraging minors to explore their gender identities.' 'Expressing any other message is forbidden—even if the counselor's clients ask for help to accept their biological sex. That is viewpoint-based and content-based discrimination in its purest form,' Justice Thomas added. AAPS in its amicus brief urged the Court to invalidate Colorado's ban on conversion therapy. This would also negate similar laws in about half the country. The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties since 1943. Contact: Andrew Schlafly, (908) 719-8608, aschlafly@ or Jane M. Orient, M.D., (520) 323-3110, janeorientmd@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
06-06-2025
- Health
- Yahoo
President of the Association of American Physicians and Surgeons (AAPS) Writes, ‘Let's Make America Healthy Again'
TUCSON, Ariz., June 06, 2025 (GLOBE NEWSWIRE) -- The Make America Healthy Again (MAHA) project is a monumental task, writes Erika L. LeBaron, DO., M.S.N., in the summer issue of the Journal of American Physicians and Surgeons. Dr. LeBaron, current president of the Association of American Physicians and Surgeons (AAPS), practices family medicine with an osteopathic and integrative approach in Manassas, Va. The role of food and medicine must be addressed as a start. Factory-made foods look and taste good, but health and nutrition are not their focus, she states. In contrast to allopathic medicine, she explains, osteopathic medicine does not primarily emphasize medications and surgery, but rather the interconnectedness of body, mind, and spirit. Disease is seen as the body being at dis-ease vs. at ease or in balance. In the late19th century, allopathic medicine accepted the concept of monomorphism, that a particular germ creates a specific disease, as taught by Louis Pasteur and Robert Koch. However, two of their contemporaries believed that the inner condition of the body was more important than the germ itself. Antoine Bechamp formulated the pleomorphism theory, which held that germs have many forms and theorized that disease is a condition of one's internal environment (terrain), Dr. LeBaron writes. When her patients ask about vaccines, she discusses the germ theory vs. terrain theory. Vaccines are not the answer to health. She points to data from a pediatric practice showing that patients who were unvaccinated or had fewer vaccines were healthier in the long run than those patients who had more vaccinations. For treating disease, pharmaceuticals are not the only option, she writes, citing examples of physicians who successfully treated COVID patients without drugs. The key lesson, she writes, is that 'every patient is unique, and we must treat the patient not the disease. We must take a root-cause analysis and whole person approach to care, not a pharma/industry guideline or protocol.' The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943. Contact: Jane M. Orient, M.D., (520) 323-3110, janeorientmd@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Business
- Yahoo
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment of Vibha Jawa, PhD, FAAPS as Chief Scientific Officer. Dr. Jawa succeeds EpiVax founder and Executive Chairwoman Annie De Groot, MD, who has transitioned from CSO to Chief Medical Officer. Dr. Jawa brings over two decades of leadership in biologics, vaccine, and gene therapy development and immunogenicity strategy to EpiVax. Most recently, she served as Executive Director of Translational Medicine at Bristol Myers Squibb, where she led bioanalytical strategy, supporting PK- and immunogenicity-related preclinical and clinical assessments across the development pipeline. She has held senior roles at Merck and Amgen where she led immunogenicity assessment efforts, supporting discovery to development. Dr. Jawa has contributed to more than 20 successful IND, BLA, and MAA filings across many therapeutic modalities, and was part of the team at the Institute of Human Gene Therapy (UPENN) that supported the first approved gene therapy product. A recognized thought leader in bioanalysis and immunogenicity from discovery through commercialization, Dr. Jawa has authored over 100 peer-reviewed publications and holds prominent roles in various renowned scientific societies and consortiums, including AAPS, IQ, SC, and EIP. She was named an AAPS fellow in 2022 for her significant contributions. "We're thrilled to welcome Vibha to the team," said Dr. Rich-Henry Schabowsky, CEO of EpiVax. "Her depth of experience in biologics, especially novel modalities, combined with her expertise in evaluating and mitigating immunogenic risk will be instrumental as we continue evolving our methods to meet the complex needs of the industry." Dr. Annie De Groot, EpiVax co-founder and CMO, added: "Dr. Jawa is the perfect scientific leader for EpiVax 2.0: the transformation of our company that began in 2024. She brings the exact energy that EpiVax needs at this juncture. I'm thrilled to be handing the baton to Dr. Jawa, who will ensure that EpiVax remains at the cutting edge of immunogenicity science— pushing boundaries, validating new ideas, building bridges between in vitro data, immunoinformatics and AI, and setting higher standards for translational immunology." Dr. Jawa will have outward and inward facing responsibilities as CSO. She will represent EpiVax at key meetings, while leading internal research and validation efforts. Her leadership will help expand the company's reach into new therapeutic areas and reinforce EpiVax as a trusted partner in biologic and vaccine development. "I'm thrilled to be joining the EpiVax team," said Dr. Jawa. "This is an extraordinary company with a long history of scientific leadership in immunogenicity assessment. I look forward to building on that legacy and continuing to refine the team's approaches, ensuring that we deliver the most accurate, insightful support." About EpiVax: EpiVax is a leader in preclinical immunogenicity assessment and sequence optimization for peptide therapeutics, biologic therapeutics, gene/cell therapies, and vaccines. EpiVax partners with a global roster of companies, agencies, and academics to accelerate immunogenicity risk assessment, immune modulation, and rapid vaccine design. Press Contact:Sarah MonizSmoniz@ View original content: SOURCE EpiVax, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
